DelveInsight's "Food Allergy Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Food Allergy market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
The report covers emerging Food Allergy drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Food Allergy treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Food Allergy: An Overview
According to the National Institute of Allergy and Infectious Diseases (NIAID), food allergy is an adverse health effect arising from a specific immune response that occurs reproducibly on exposure to a given food. Food allergens are the parts of food or ingredients within food (usually proteins) recognized by immune cells. When an immune cell binds to a food allergen, a reaction occurs that causes the symptoms of food allergy. “Allergy” and “allergic disease” refer to conditions that involve changes to the immune system. These immune system changes fall into two categories: IgE-mediated and Non-IgE-mediated.
The cause of food allergy can be functional genetic variants in the IL-12 receptor b1, Toll-like receptor 9, and thymic stromal lymphopoietin genes, and even IL-4 gene polymorphism have been associated with an increased risk of food sensitization.
Food Allergy Market Key Facts
-
In the year 2022, the total prevalent cases of Food allergy (FA) were 32,885,000+ cases in the 7MM which will increase by 2032.
-
Among the EU5 countries, Spain has the highest number of prevalent cases of Food Allergy, which were 4,581,000+ cases in 2022.
-
The UK has the lowest prevalent population of Food allergies among the 7MM, with 2,032,000+ cases in 2022.
-
The prevalence of food allergy varies widely in different geographical locations, depending upon the influence of cultures on dietary habits. For example, peanut allergy is one of the most common causes of food anaphylaxis in the United States and the United Kingdom, but it is not as common in Italy and Spain, where peanut consumption is significantly lower.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Food Allergy pipeline therapies. It also thoroughly assesses the Food Allergy market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete detail of the market trend for each marketed Food Allergy drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MOA), Route of Administration (ROA), molecule types, competition with other therapies, brand value, and their impact on the market.
Food Allergy Epidemiology Assessment
The epidemiology section provides insights into the historical, current, and forecasted Food Allergy epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted Food Allergy epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pools, future trends, and views of key opinion leaders.
The Report Covers the Food Allergy Epidemiology, Segmented as -
-
Total Prevalent Cases of Food Allergy [2019–2032]
-
Age-specific cases of Food Allergy [2019–2032]
-
Etiology-specific cases of Food Allergy [2019–2032]
Food Allergy Drugs Uptake and Pipeline Development Activities
The drug uptake section focuses on the uptake rate of potential drugs recently launched in the Food Allergy market or expected to be launched during the study period. The analysis covers the Food Allergy market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the market dynamics by drug sales, the most rapid drug uptake, and the reasons behind the maximal use of particular drugs. Additionally, it compares Food Allergy drugs based on their sale and market share.
The report also covers the Food Allergy pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key Food Allergy companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn How the Food Allergy Market Will Evolve and Grow by 2032 @
https://www.delveinsight.com/sample-request/food-allergy-market-insights
Food Allergy Therapeutics Analysis
The treatment of food allergy relies on avoidance of the foods to which an individual is allergic, as a therapeutic intervention (tertiary prevention) in patients with food allergy. Unfortunately, severe reactions such as anaphylaxis may occur despite best efforts to avoid them. Epinephrine is the first-line medication for the treatment of anaphylaxis. Additional medications include H1 and H2 antihistamines, corticosteroids, and prostaglandin synthetase inhibitors These drugs are only symptomatic, do not modify the natural course of the disease.
Several major pharma and biotech companies are developing therapies for Food Allergies. Currently, DBV Technologies is leading the therapeutics market with its Food Allergies drug candidates in the most advanced stage of clinical development.
Food Allergy Companies Actively Working in the Therapeutics Market Include
Aimmune Therapeutics, Inc., Alladapt Immunotherapeutics, Inc., Aravax, Astrazeneca, Camallergy, COUR Pharmaceutical Development Company Inc., DBV technologies, Genentech, Inc., GI Innovation, Inimmune, InnoUp Farma S.L., Mabylon, Merck & Co, Novartis Pharmaceuticals, Regeneron Pharmaceuticals, Rho Federal Systems Division, Inc., Siolta Therapeutics, Vedanta Biosciences, Inc., and many others.
Emerging and Marketed Food Allergy Therapies Covered in the Report Include:
-
ADP101: Alladapt Immunotherapeutics
-
Dupilumab: Regeneron Pharmaceuticals
-
INP20: InnoUp Farma S.L.
-
Ligelizumab: Novartis Pharmaceuticals
-
Omalizumab: Genentech, Inc. /Novartis Pharmaceuticals/Rho Federal Systems Division, Inc.
-
Viaskin Peanut: DBV Technologies
And Many More
The Report Covers the In-depth Assessment of the Emerging Drugs & Key Companies. Download the Sample Report to Learn More @
https://www.delveinsight.com/sample-request/food-allergy-market-insights
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Food Allergy Competitive Intelligence Analysis
4. Food Allergy Market Overview at a Glance
5. Food Allergy Disease Background and Overview
6. Food Allergy Patient Journey
7. Food Allergy Patient Population and Epidemiology Trends (In the US, EU5, and Japan)
8. Food Allergy Treatment Algorithm, Current Treatment, and Medical Practices
9. Food Allergy Unmet Needs
10. Key Endpoints of Food Allergy Treatment
11. Food Allergy Marketed Therapies
12. Food Allergy Emerging Drugs and Latest Therapeutic Advances
13. Food Allergy Seven Major Market Analysis
14. Attribute Analysis
15. Food Allergy Market Outlook (In US, EU5, and Japan)
16. Food Allergy Companies Active in the Market
17. Food Allergy Access and Reimbursement Overview
18. KOL Views on the Food Allergy Market
19. Food Allergy Market Drivers
20. Food Allergy Market Barriers
21. Appendix
22. DelveInsight Capabilities
23. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download the Sample PDF to Learn More About the Key Offerings of the Report @
https://www.delveinsight.com/sample-request/food-allergy-market-insights
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Other Trending Healthcare Reports by DelveInsight
"Substance (Drug) Abuse Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Substance (Drug) Abuse market size, share, trends, and growth analysis in the seven major markets (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. Moreover, it also covers the current treatment practices, emerging drugs, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Substance (Drug) Abuse market.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
